Monitoring of CF lung disease

F. Ratjen (Toronto, Canada), I. Balfour-Lynn (London, United Kingdom)

Source: ERS course 2015
Number: 6
Disease area: Paediatric lung diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Ratjen (Toronto, Canada), I. Balfour-Lynn (London, United Kingdom). Monitoring of CF lung disease. ERS course 2015

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CF lung disease and lung transplantation
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

CF lung disease and lung transplantation
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

CF lung disease and lung transplantation
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020


Practical treatment of CF lung disease
Source: ERS course 2015
Year: 2015

Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016

Lung function measurements versus structural lung disease in CF
Source: Breathe 2008; 5: 65
Year: 2008

Challenging infections in advanced CF lung disease
Source: Annual Congress 2013 –Challenges in lung transplantation for cystic fibrosis
Year: 2013


Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018


Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016



Management of the CF lung pathogens
Source: ERS course 2015
Year: 2015


Neutrophils in CF lung disease
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008


Aging in lung disease
Source: International Congress 2016 – The future is now: the challenge of ageing in respiratory medicine
Year: 2016


Assessment of fibrosis in lung biopsies from the European childhood interstitial lung disease (chILD) registry
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020




Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014


Paediatric interstitial lung disease
Source: ERS Course 2016
Year: 2016




Paediatric interstitial lung disease
Source: Eur Respir Mon; 2009: 46: 319–354
Year: 2009

Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer
Source: International Congress 2016 – Orphan diseases I
Year: 2016